David C. Myles, CH. DISCOV. & NON-CLIN Development Officer at Olema Pharmaceuticals, Inc. (OLMA), sold 27,058 shares at $14.87 ($389K) on 2023-11-21, disclosed to the SEC on 2023-11-22.
Open-market sale of $389k OLMA by CH. DISCOV. & NON-CLIN Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.87 | 6,776 | $101K | 25.9% |
| 2 | $14.87 | 6,776 | $101K | 25.9% |
| 3 | $15.32 | 200 | $3K | 0.8% |
| 4 | $13.89 | 6,653 | $92K | 23.7% |
| 5 | $13.89 | 6,653 | $92K | 23.7% |
| Total | $14.39 avg | 27,058 |
| $389K |
| 100% |
| Filing → |
| OLMA | SELL | 2024-12-11 | $467K | — | Filing → |
| OLMA | SELL | 2023-11-13 | $4K | — | Filing → |
| OLMA | SELL | 2023-11-03 | $312K | — | Filing → |